Literature DB >> 25914466

Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.

Richard A Schatz1, Qing Zhang1, Nilesh Lodhia1, Jonathan Shuster1, Phillip P Toskes1, Baharak Moshiree1.   

Abstract

AIM: To investigate, in the largest cohort to date, patient characteristics and associated risk factors for developing small intestinal bacterial overgrowth (SIBO) using the D-Xylose breath test (XBT).
METHODS: We performed a retrospective cross-sectional study to analyze patient characteristics who underwent the XBT for evaluation of SIBO. Diagnostic testing with the XBT was performed based on a clinical suspicion for SIBO in patients with symptoms of bloating, abdominal pain, abdominal distension, weight loss, diarrhea, and/or constipation. Consecutive electronic medical records of 932 patients who completed the XBT at the University of Florida between 2005 and 2009 were reviewed. A two-way Analysis of Variance (ANOVA) was used to test for several associations including age, gender, and body mass index (BMI) with a +XBT. A two-way ANOVA was also performed to control for the differences and interaction with age and between genders. A similar analysis was repeated for BMI. Associations between medical conditions and prior surgical histories were conducted using the Mantel-Haenszel method for 2 by 2 contingency tables, stratified for gender. Reported odds ratio estimates reflect the odds of the prevalence of a condition within the +XBT group to that of the -XBT group. P values of less than 0.05 (two-sided) were considered statistically significant.
RESULTS: In the 932 consecutive eligible subjects studied, 513 had a positive XBT. A positive association was found between female gender and a positive XBT (P = 0.0025), and females with a positive test were, on average, greater than 5 years older than those with a negative test (P = 0.024). The mean BMI of positive XBT subjects was normal (24.5) and significantly lower than the subjects with a negative XBT (29.5) (P = 0.0050). A positive XBT was associated with gastroesophageal reflux disease (GERD) (OR = 1.35; 95%CI: 1.02-1.80, P = 0.04), peptic ulcer disease (PUD) (OR = 2.61; 95%CI: 1.48-4.59, P < 0.01), gastroparesis (GP) (OR = 2.04; 95%CI: 1.21-3.41, P < 0.01) and steroid use (OR = 1.35; 95%CI: 1.02-1.80, P = 0.01). Irritable bowel syndrome, independent proton-pump inhibitor (PPI) usage, or previous abdominal surgery was not significantly associated with a positive XBT. No single subdivision by gender or PPI use was associated with a significant difference in the odds ratios between any of the subsets.
CONCLUSION: Female gender, lower BMI, steroid use, PUD, GERD (independent of PPI use), and GP were more prevalent in patients with SIBO, determined by a positive XBT. Increasing age was associated with SIBO in females, but not in males.

Entities:  

Keywords:  Bacteria; Breath tests; Gastroparesis; Intestine; Irritable bowel syndrome; Proton pump inhibitors; Small; Xylose

Mesh:

Substances:

Year:  2015        PMID: 25914466      PMCID: PMC4402304          DOI: 10.3748/wjg.v21.i15.4574

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

Review 1.  D-xylose testing.

Authors:  R M Craig; E D Ehrenpreis
Journal:  J Clin Gastroenterol       Date:  1999-09       Impact factor: 3.062

2.  Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.

Authors:  Thomas L Abell; Michael Camilleri; Kevin Donohoe; William L Hasler; Henry C Lin; Alan H Maurer; Richard W McCallum; Thomas Nowak; Martin L Nusynowitz; Henry P Parkman; Paul Shreve; Lawrence A Szarka; William J Snape; Harvey A Ziessman
Journal:  J Nucl Med Technol       Date:  2008-02-20

3.  Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation.

Authors:  Brynie Slome Collins; Henry C Lin
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

Review 4.  Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation.

Authors:  Joseph Romagnuolo; Dan Schiller; Robert J Bailey
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

Review 5.  Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.

Authors:  Eamonn M M Quigley
Journal:  J Dig Dis       Date:  2007-02       Impact factor: 2.325

6.  Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.

Authors:  R S Choung; K C Ruff; A Malhotra; L Herrick; G R Locke; W S Harmsen; A R Zinsmeister; N J Talley; Y A Saito
Journal:  Aliment Pharmacol Ther       Date:  2011-03-13       Impact factor: 8.171

7.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 8.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

9.  Characteristics of the intestinal epithelial barrier during dietary manipulation and glucocorticoid stress.

Authors:  J C Spitz; S Ghandi; M Taveras; E Aoys; J C Alverdy
Journal:  Crit Care Med       Date:  1996-04       Impact factor: 7.598

10.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

View more
  7 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  Predictors of Small Intestinal Bacterial Overgrowth in Symptomatic Patients Referred for Breath Testing.

Authors:  Jeremy Liu Chen Kiow; Ratiba Bellila; Amelie Therrien; Sacha Sidani; Mickael Bouin
Journal:  J Clin Med Res       Date:  2020-09-21

Review 3.  Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects.

Authors:  Chethan Ramprasad; Jane Yellowlees Douglas; Baharak Moshiree
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

4.  Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study.

Authors:  Thorsten Brechmann; Andre Sperlbaum; Wolff Schmiegel
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

5.  Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.

Authors:  Uday C Ghoshal; Sanjeev Sachdeva; Ujjala Ghoshal; Asha Misra; Amarender Singh Puri; Nitesh Pratap; Ayesha Shah; M Masudur Rahman; Kok Ann Gwee; Victoria P Y Tan; Tahmeed Ahmed; Yeong Yeh Lee; B S Ramakrishna; Rupjyoti Talukdar; S V Rana; Saroj K Sinha; Minhu Chen; Nayoung Kim; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-10-10

6.  Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender.

Authors:  Carolyn Newberry; Ann Tierney; Octavia Pickett-Blakely
Journal:  Biomed Res Int       Date:  2016-03-17       Impact factor: 3.411

7.  Outcome of breath tests in adult patients with suspected small intestinal bacterial overgrowth.

Authors:  Johanna Mattsson; Maria Teresa Minaya; Milka Monegro; Benjamin Lebwohl; Suzanne K Lewis; Peter Hr Green; Reidun Stenberg
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.